Polyreactive antibodies (Abs) constitute a major proportion of the early Ab repertoire and are an important component of the natural defense mechanisms against infections. They are primarily immunoglobulin M (IgM) and bind a variety of structurally dissimilar self and exogenous antigens (Ags) with moderate affinity. We analyzed the contribution of Ig polyvalency and of heavy (H) and light (L) chain variable (V) regions to polyreactivity in recombinatorial experiments involving the V.-diversity(D)-JH and VK-J~ gene segments of a human polyreactive IgM, monoclonal antibody 55 (mAb55), and those of a human monoreactive anti-insulin IgG, mAb13, in an in vitro Cyl and C~ human expression system. These mAbs are virtually identical in their V, and VK gene segment sequences. First, we expressed the V.-D-J. and V~-J~ genes of the IgM mAb55 as V segments of an IgG molecule. The bivalent recombinant IgG Ab bound multiple Ags with an efficiency only slightly lower than that of the original decavalent IgM mAb55, suggesting that class switch to IgG does not affect the Ig polyreactivity. Second, we coexpressed the mAb55-derived H or K chain with the mAb13-derived K or H chain, respectively. The hybrid IgG Ab bearing the mAb55-derived H chain V segment paired with the mAb13-derived ~ V segment, but not that bearing the mAb13-derived H chain V segment paired with the mAb55-derived K V segment, bound multiple Ags, suggesting that the Ig H chain plays a major role in the Ig polyreactivity. Third, we shuffled the framework 1 (FR1) -FtL3 and complementarity determining region 3 (CDR3) regions of the H and K chain V segments of the mAB55-derived IgG molecule with the corresponding regions of the monoreactive IgG mAb13. The mAb55-derived IgG molecule lost polyreactivity when the H chain CDR3, but not the FR1-FR3 region, was replaced by the corresponding region of mAb13, suggesting that within the H chain, the CDR3 provides the major structural correlate for multiple Ag-binding. This was formally proved by the multiple Ag-binding of the originally monoreactive mAb13-derived IgG molecule grafted with the mAb55-derived H chain CDR3. The polyreactivity of this chimeric IgG was maximized by grafting of the mAb55-derived K chain FK1-FIL3, but not that of the K chain CDK3. The mAb55-derived K chain FR1-FK3 (an unmutated V~ 325 segment), however, failed to yield a polyreactive Ab when grafted onto an IgG that was in all other parts identical with mAb13. Rather, this chimeric molecule showed full specificity for insulin. Thus, the polyreactivity of the human mAb55 can be fully preserved after Ig class switch, and depends primarily on the contribution of structures that are generated through somatic rearrangement events (H chain CDK3), and structures that represent the expression of an unmutated gene (VK 325 segment).
some of the high-affinity autoantibodies emerging in patients with autoimmune disease.
The multiple Ag-binding activity and primordial Ig class, mainly IgM, of natural Abs contrast with the exquisite specificity and mature Ig class, mainly IgG, of the Ag-induced Abs. Despite their moderate intrinsic affinity, polyreactive Abs generally display a high avidity for Ag due to the decavalency of the predominant IgM class. Consequently, their effectiveness in binding Ag would be expected to decrease dramatically, because of a decrease in overall avidity, after Ig class switch and substitution of a 3' for a # H chain (2) . The characteristic spectra of Ag-binding activities of polyreactive Abs presumably reflect fundamental differences in the structure of their Ag-binding sites, as compared to those of Aginduced (monoreactive) specific Abs, although the limited molecular data available have failed to yield definitive clues to such differences (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . It has been suggested that polyreactive Abs rely on the utilization of selected V. genes, possibly in unmutated configuration, for the recognition of multiple Ags (1, 11, 12) . However, recent data have shown that these Abs use various arrays of different V. and V~ gene segments, as well as different D, Jtt, and/or J~ gene segments, suggesting that the somatically generated H chain CDR3 may provide the crucial structural correlate for multiple Agbinding (6, 13, 14) .
To analyze the contribution of different Ig V regions to polyreactivity and to assess the impact of class switch to IgG on the ability of an originally polyreactive IgM Ab to bind multiple Ags, we performed recombinatorial experiments involving a human polyreactive IgM, mAb55 (3) and a human monoreactive anti-iiasulin IgG, mAb13 (15) . These two mAbs were chosen because they use the same V. and V~ gene segments in a highly similar configuration and with highly conserved FR structures (7, 16) . Analysis of the chimeric molecules generated by replacing different portions of the polyreactive mAb55 H and L chain V segments with the corresponding portions of the monoreactive mAb13 and by expressing the "wild-type" or recombinant H and L chain V gene segments juxtaposed with the same Cyl and C, chains, respectively, demonstrating that Ab polyreactivity was not affected by class switch from IgM to IgG and was dependent on the structure of the H chain CDR3 and that of the unmutated V~ 325 framework 1 (FR1) 1 -FR3 segment.
Materials and Methods
Cloning and Sequencing of the V,,-D-J, and VJ~ Genes of mAb55 and mAbl3. The polyreactive IgM ~, mAb55, and the monore-1 Abbreviations used in this paper: Avrd, relative avidity (g//~l); ds, double stranded; FR, framework region; IDDM, insulin-dependent (type I) diabetes mellitus; ss, single stranded.
active anti-insulin IgG K, mAbl3, were generated by EBV transformation and somatic cell hybridization techniques using peripheral B cells from a healthy subject and a patient with insulindependent diabetes mellitus (IDDM), respectively (3, 15) . IgM K mAb55 was shown to be at least pentameric by size fractionation analysis on a Superose 12 column (Pharmacia LKB Biotechnology, Piscataway, NJ).
The sequences of the mAb55 V.-D-J., mAb13 V.-D-J., and mAb13 V~-J~ gene segments have been reported (7, 16) ; that of the mAb55 V.-J. gene segment was derived for the purpose of these studies using described procedures (7) (8) (9) (10) . These sequences are depicted in Fig. 1 A, and are summarized in Table 1 . The two mAb V. gene sequences were 96.4% identical throughout the coding area, differing from that of the germline Hll gene (17) in five (mAb13) and nine (mAb55) nucleotides. Both mAbs utilized the DXP'I gene (18) but in different reading frames, and complemented by different unencoded nucleotides and different truncated J. genes (19) . The sequences of the mAb55 and mAb13 V.III genes were 93.8% identical throughout the coding area. The mAb55 V~ gene sequence was identical to that of the germline kv325 gene (20) except for a silent T ~ G change at position 288; that of the mAb13 V. gene differed in six nucleotides from the sequence of the germline kv3g gene (21) . Both mAbs used a JA gene (22) , Expression Vectors. The pcDNAIG and pSXRDIG plasmid vectors (23) were used for the in vitro expression of the human Ig V.-D-J. and V,-J. gene segments, respectively, pcDNAIG is a mammalian expression vector derived from pcDNAI/Neo (Invitrogen Corp., San Diego, CA) (Fig. 2 A) . It encodes a human CMV promoter, a murine leader sequence, a whole human IgG1 H chain, and a Rous sarcoma virus (RSV) LTR-driven neomycin resistance gene. pSXRDIG is a mammalian expression vector derived from pUC18 (Fig. 2 B) . It contains a SV40 promoter, a murine leader sequence, a whole human Ig K L chain, and a DHFR gene for selection by methotrexate, Introduction of mAb55 and mAbl3 V.-D-J,, Gene Segments into pcDNAIG Vector. The unique HindlIl and XhoI sites, 5' and 3" respectively, of the leader-V.-D-J, gene segment in pcDNAIG were utilized for the introduction of the rearranged mAb55 or mAb13 V.-D-JH gene segment (Fig. 2 A) . The mouse H chain leader sequence of pcDNAIG and the V.-D-J. gene segment of mAb55 (or mAbl3) were amplified in separate PCRs (PCR 1 and PCR 2), and joined by "recombinant" PCR to yield the recombinant "leader-mAb55 (or mAb13) V.D-JH" gene segment (Fig.  3 A) , using the sense H-leader (5' gggaagcttctcaccatgggatgg 3') and the antisense H-Ovl (5' GCTGCACCTCacactggacacctgcagagaaag 3') primers; and the sense H-Ov2 (5' ttctctgcaggtgtccagtgtGAGGTGCAGCTG 3') and the antisense H-FR4 (5' gggctcgagactcaccTGAGGAGACGGTAACCG 3' for mAb55 J.6 or 5'gggctc~aI~actcaccTGAGGAGACAGTGACCA 3' for mAb13 J.2) primers (uppercase letters denote the sequences derived from the Ig V gene sequence ofmAb55 or mAb13; lowercase letters denote the sequences derived from the expression vectors; sequences of restriction sites are underlined). The sequences of the primers used at the ends to be joined (H-Ovl and H-Ov2) were complementary and allowed for partial annealing of the PCR 1 and PCR 2 products and performance of a recombinant PCR by addition of excess Figure 1 . Nucleotide (A) and deduced amino acid (/3) sequences of the V., D-J., V., and J, gene segments of mAb55 and mAb13. The top sequence in each duster is that of the germline gene to which the remaining sequences of the cluster were compared. Dashes indicate identities. Solid lines on the top of each cluster depict CDRs. Dots represent deletions. Lowercase letters denote untranslated sequences. The sequences encompassed by the GIII-FR3 and IdII-FR3 primers are underlined. The present sequences are available from EMBL/GenBank/DDBJ under accession numbers 1.08084, b32748, D-16833, and D-16834.
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Structural Correlates for Antibody Polyreactivity H-leader and H-FR4 primers (Fig. 3 A) . The recombinant fragment was sequenced, to ensure that no unintended mutations were introduced during PCR amplification (8, 10, 16, 24) , digested with HindlII and XhoI, ligated into pcDNAIG previously digested with HindlII and XhoI and freed of its original Va-D-J. gene segment.
CG-A-C-A--GG---

~IH-FR3
B.
The recombinant pcDNAIG plasmids were amplified by transformation of competent MC1061/P3 cells (Invitrogen Corp.), and selection with ampicillin and tetracycline. Plasmid DNA was isolated using a plasmid kit (Qiagen Inc., Chatsworth, CA).
Introduction of mAb55 and mAbl3 V.-J. Gene Segments into pSXRDIG Vector.
The unique HindlII and XhoI sites, 5' and 3" respectively, of the leader-V.-J, gene segment in pSXRDIG, were utilized for the insertion of the mAb55 or mAb13 V.-J~ gene segment (Fig. 2 B) . The routine K-leader sequences ofpSXRDIG and the mAb55 (or mAb13) V~-J. gene segment were amplified in separate PCRs and joined by recombinant PCR (Fig. 3 A) . The sequences of the primers used for these PCRs were as follows: sense It-leader (5' gggaagcttatcaagatgaagtca 3'), antisense K-Ovl (5' CAACACAATTTCgcatctggaacctgcagtcagaga 3'); sense K-Ov2 (5' gcaggttccagatgcGAAATTGTGTTGACGCAGTCT 3'), antisense K-FR4 (5'gggctcgagacttacgTTTGATCTCCACCTTGG 3'). The recombinant fragment, leader-mAb55 V~-J. or leader-mAb13 V~-J., was inserted into pSXRDIG after digestion with HindlII and XhoI. Recombinant pSXRDIG plasmids were amplified in competent DH5c~ cells by selection with ampicillin.
Construction of Recombinant (rec)V.13-55 and recV.55-13 Gene Segments,
The method used to construct the recV.13-55 gene segment is schematized in Fig. 3 B, The sequence encoding the leader through the FR3 area of mAb13 H chain V segment was PCR amplified using the sense H-leader and antisense GIII-FR3 B (5' CGGCTCTCAGACTGTTCATTGC 3') primers ( Fig. 1 A) . The sequence encoding the FR3 though FR4 area of mAb55 H chain V segment was PCR amplified using the sense GIII-FR3 A (5' GCAATGAACAGTCTGAGAGCCG 3') (the reverse complement of GIII-FR3 B) and the antisense H-FR4 primers. The two amplified fragments were purified and joined by recombinant PCR. The same primers, except for the H-FR4 primer, and recombinant PCR were used for the construction of the recV.55-13 gene segment. The recV.13-55 and recV.55-13 gene segments were introduced into pcDNAIG as described above. 
Construction of recV.13-55 and reeve55-13 Gene Segments. The
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Structural Correlates for Antibody Polyreactivity method used to construct the recVA3-55 and recV~55-13 gene segments was similar to that used for construction of the recV, segments (Fig. 3 B) . The sequence encoding the leader though the FR3 area of mAb13 and mAb55 r V segment was PCK amplified using the sense r-leader and antisense r,/II-FR3 B (5' GCTGACAG-TAATACACTGCAAAATCTTC 3') primers (Fig. 1 A) . The sequence encoding the FR3 though FR4 area of mAb55 or mAb13 r V segment was amplified using the sense gUI-FR3 A (5' GAA-GATTTTGCAGTGTATTACTGTCAGC 3') (reverse complement of rIII-FR3 B) and antisense r-FR4 primers. For each pair of segments, the two amplified DNAs were purified, joined by recombinant PCK, and introduced into pSXRDIG.
Cell Culture and Transfection. Mammalian F3B6 cells were used in all transfection experiments. F3B6 is the Ig nonsecretor humanmouse heterohybridoma used as fusion partner for the generation of mAh13 and mAb55 (3, 15) . F3B6 cells were cultured in RPMI-1640 (BioWhittaker, Walkersxdlle, MD) with 10% FCS, 1% L-glutamine, and antibiotics (FCS-RPMI), washed, and then resuspended in FCS-RPMI at 107/ml. The cell suspension (750/~l) containing pcDHAIG (4/zg) and FSXRDIG (4/~g) vector DNA was transferred into an ice-cold electroporation cuvette with a 0.4-cra gap (Invitrogen Corp.). After application of an electric pulse of 750 V/cm with a capacitance of 1,000 IzF using the Electroporator TM (Invitrogen Corp.) and a power supply (model 4000; GIBCO BRL, Gaithersburg, MD), the cuvette was kept on ice for 10 min. Ceils were then transferred to a flask containing 10 ml of tavwarmed FCS-RPMI. After a 48-h culture, cuhare medium was changed to selective medium containing 0.4 mg/ml of G418 (Genetidn; GIBCO BRL), and cells were distributed into 96-well flat-bottom plates. Neomycin only was used as selecting agent, because in transfectants expressing only pcDNAIG (H chain), the accumulation of unsecretable H chain molecules leads to cell death. Clumps of transformant cells were detected within 7-10 days. After 2 wk, culture fluids were tested by ELISAs using plates coated with goat F(ab')z fragment specific to human Ig # + 7 + c~ H chains. Double y1 and r chain producer cells were identified by developing separate ELISA plates with peroxidase-conjugated affinity-purified goat anti-human Ig y and r chain probes (Cappel, Organon Teknika Corp., Durham, NC) (3) (4) (5) . In each transfection, 5 -12 clones secreting IgG r were generated. The three most efficient secretors were expanded and frozen.
Ab Purification, Binding Assays, and Measurement of Relative Avidity (Av,a). IgG mAbs were purified from culture supernatant by 50% ammonium sulfate precipitation followed by absorption of the solubilized IgG onto a GammaBind G-Sepharose column (Pharmacia LKB Biotecbnology), and elution with 100 mM glycine-HC1 buffer (pH 2.7). Eluates were brought to pH 7.5 by addition of neutralizing buffer (pH 9.0), dialyzed against PBS, and stored in aliquots at 4~ mAb binding to human recombinant insulin (Eli Lilly Research Laboratories, Indianapolis, IN), single stranded (ss)DNA, human recombinant IL-13 (BASF Biotech Corp., Worcester, MA), polyclonal human IgG Fc fragment, tetanus toxoid, and BSA was measured using appropriate ELISAs (3) (4) (5) . IgG bound to solid-phase IgG Fc fragment were measured using a peroxidaseconjugated, affinity-purified goat anti-human Ig r chain probe (Cappel, Organon Teknika Corp.). Binding of mAbs to soluble insulin was measured by competitive ELISA (3-10, 15, 16) . Briefly, increasing amounts (0.25-100 #g) of soluble insulin were mixed with a constant amount of Ab in 100/zl of PBS containing 0.05% Tween 20 (PBS-Tween) and 1% BSA. After an 18-h incubation at room temperature, the mixtures were transferred into ELISA plates precoated with insulin. After a 1-h incubation and subsequent washing with PBS-Tween, the amount of Ab bound to the solidphase insulin was measured. For each Ab, the binding measured after incubation under identical conditions but in the absence of soluble iasalin (always >1.00 OI) at 492 rim; negative control <0.04) represented 100% binding activity. The concentration (g/#l) of sohble insulin fielding 50% inhibition of Ab binding to solidphase insulin was used to express the Av~. (3) . The anti-insulin mAhl3 is a prototypic Ag,-indmed "mature" human aumanfibody~ that it stemmed by affinity maturation from the iastflin-stmcific autoantibody response in a patient with IDDM, andis a monoreacfive and highly specific [gG (21, 22) . Deduced amino acid u:qtumces of mAb$5 and mAb13 V,-~D-J, genes were 94.9% identical throughout the V= area, differing in four amino acids in the CDKI and CDK2 and one amino acid in the FR3, but were highly divergent in length and composition of the somatically generated CDR3 (Fig. 1 B) . The two mAb H chain FK4 sequences differed only in two amino acids. The two mAb V,III segment sequences were 87.6% identical, differing in four amino acids (including one deletion) in the CDK1 and CDK2 and seven in the FKs (Fig. 1 B) . The mAb55 Vr segment represented the expression of an unmutated Vr325 gene. The two mAb r chain CDK3s were identical in length, but differed in five of the nine amino acids. The r chain FK4 sequences were identical.
Results
Structure and Specificity of the Human
Thus, mAb55 and mAb13 were highly similar or identical in their V., H chain FK4, V~ and r chain FR4 segments, but substantially different in their H chain CDK3S, and, to a lesser extent, r chain CDR3s. The mAb55 and mAb13 dosesaturable bindings to human insulin, human IL-1/3, ssDNA, human IgG Fc fragment, tetanus toxoid, and BSA are depicted in Fig. 4 , A and C. The mAb55 Avr,i for human recombinant insulin, used as a measure of the mAb ability to bind Ag in the fluid phase, was approximately two orders of magnitude lower than that of mAb13 ( Table 1) .
Effect of Class Switch on mAb55
Polyreactivity. Decavalency has been claimed to be an important factor in IgM polyreactivity. To verify whether the pentameric structure of the mAb55 is in fact a major determinant of the ability of this Ab to bind multiple Ags, we juxtaposed the mAb55-derived V,-D-J, and V,-JK gene segments with human Cy1 and CK genes, respectively, by recombination into the Cy1 pcD-NAIG and C~ pSXRDIG vectors, and expressed them by simultaneous transfection of F3B6 cells. 10 stable transformant clones secreting human lgG1 r were generated, three of which were expanded to produce recombinant mAb55 IgG1 r molecules (designated reclgG55). The purified monomeric reclgG55 Ab
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Ichiyoshi and Casali (19) . II The sequence of germline kv325 gene has been reported by Kipps et al. (20) . 82 Jr genes have been reported by Heiter et al. (22) . ** The sequence of germline kv3g gene has been reported by Pech et al. (21) .
bound in a dose-saturable fashion and with an efficiency only slightly lower than that of the original pentameric IgM mAb55 to the six self and exogenous Ags tested (Fig. 4, A and B) . This slightly lower multiple Ag-binding efficiency was reflected in a slightly lower Avra for insulin of the reclgG55 when compared with its IgM counterpart (8.5 x 10 -7 vs. 5.0 x 10 -7 g//A). These experiments show that class switch from IgM to IgG does not significantly affect the ability of mAb55 to bind multiple Ags, and that polyreactivity is a function inherent to the V portion of the Ig molecule.
Contribution of the mAb55 V,-D-J, Segment to Polyreactivity.
To evaluate the relative contribution of the whole V.-D-J. and V~-J~ segments to the polyreactivity of the reclgG55 Ab, we first inserted the V,-D-JH and V,-J, gene segments derived from mAb13 into the C3,1 pcDNAIG and C, pSXRDIG vectors, respectively, and simultaneously expressed the recombinant Ig chains by transfection of F3B6 cells. Pairing of the recombinant H and K chains yielded a fully functional molecule, designated reclgG13, which bound insulin in a dose-saturable fashion and with an efficiency comparable to that of the original mAb13 (Avra for insulin was 7.5 x 10 -9 g//zl, compared with 4.9 x 10 -9 g//zl for mAb13) but none of the other Ags tested (Fig. 4, C and D) .
Having shown that the expression ofmAb55 and mAb13 V gene segments juxtaposed with the same Cyl and CK genes in a recombinant system did not essentially alter the distinct original Ag-binding features of the two mAbs, we constructed: (a) the hybrid IgG molecule recV.55-55/recVA3-13 bearing the mAb55-derived H chain V segment and the mAb13-derived K chain V segment, and (b) the hybrid IgG molecule recV.13-13/recV~55-5 bearing the mAb13-derived H chain V segment and the mAb55-derived x chain V segment. Although somewhat less efficiently (Avro~ for insulin, 1.2 x 10 -6 g//xl), the recV.55-55/VA3-13 hybrid Ab bound multiple Ags in a fashion similar to that of the reclgG55 (recV.55-55/recV~55-55) and the original polyreactive IgM mAb55 molecules (Fig. 4 , E,/3, and A). In contrast, the recVa13-13/recV~55-55 hybrid Ab did not bind any of the Ags tested (Fig. 4 F) . The failure of this Ab to bind insulin may have been due to a "damping" effect by the recV,55-55 segment on the inherent insulin specificity of the recV.13-13 segment, since the recV.13-13 segment showed full expression of insulin specificity (Ichiyoshi, Y., M. Zhou, and P. Casali, manuscript submitted for publication) when paired with the Vr segment of mAbl0 (14) which is very different in sequence from the Vr segment of mAb13 or mAb55. This phenomenon is reminiscent of the finding by Radic et al. (25) who showed that the H chain of murine anti-DNA 3H9 Ab contains most or all of the required determinants for double stranded (ds)DNA binding, but its pairing with certain L chains can result in abrogation of this binding. Thus, the mAb55 V,-D-J. segment is necessary and sufficient for multiple Ag-binding.
Role of the H Chain CDR3 in mAb55
Polyreactivity. To determine whether mAb55 polyreactivity rests in the V, segment itself (Flkl through FIL3 sequence) or the somatically generated H chain CDR3, we evaluated the functional role of the discrete V. segment and CDR3, using: (a) the recV.13-55 gene segment, constructed by juxtaposing the mAb13-derived V. sequence with the mAb55-derived D-J, sequence; and (b) the recV.55-13 gene segment, constructed by juxtaposing the mAb55-derived V. sequence with the mAb13-derived D-J. sequence. In these gene recombinations, the last residue of the V. FR3, which is a Val in mAb55 and an Arg in mAb13, was regarded as part of the CDR3, because FR residues adjacent to CDR might contribute to the conformation of the CDR loop itself (26) . The two chimeric gene segments were inserted into the Cyl pcDNAIG vectors, and separately expressed by transfection of F3B6 cells along with the VK-JK gene segment derived from the polyreactive mAb55 (recVK55-55) to yield the recV.13-55/recVK55-55 and recV.55-13/recV~55-55 Ab mol-ecules. Consistent with the role of the H chain CDR3 in providing the structural correlate for polyreactivity, the recV.13-55/recV~55-55, but not the recV.55-13/recV~55-55, IgG Ab bound multiple Ags (Fig. 4, G and H) . In fact, the extent to which the recV.13-55/recV~55-55 molecule bound to the Ags tested was comparable (AV=I for insulin, 9.4 x 10-7 g//zl) to that of the reclgG55 and that of the original IgM mAb55 (Fig. 4, B and A) , Thus, the CDR3, not the V. segment, is the crucial element providing the structural correlate for the polyreactivity displayed by the mAb55 H chain. This contention was further strengthened by the demonstration that grafting of the mAb55-derived H chain CDR3 onto a molecule which was in all other parts identical to mAb13 enabled the molecule to bind multiple Ags. The Ab resulting from the pairing of the recV,13-55 gene segment with the recVA3-13 gene segment bound to all Ags tested, although less efficiently, in a fashion similar to that of the recV,55-55/recVA3-13 hybrid molecule, which was encoded by the whole arm mAb55-derived V.-D-J. gene segment (Fig. 4, I and E).
Role of the V~ Segment in mAb55 Polyreactivity, Analysis of the recV.13-55/recVA3-13 molecule emphasized the role of the H chain CDR3 in Ag-binding. It also indicated that the mAb55 K chain contributed to polyreactivity. This was initially suggested by the slightly suboptimal binding to multiple Ags displayed by the recV.55-55 segment paired with the recVA3-13 segment (Fig. 4 E) . To determine which portion of the mAb55 VK chain was synergistic with the H chain in binding Ags, we substituted the V~ FR1-FR3 or K chain CDR3-FR4 sequence of the recV.13-55/V~13-13 molecule with the respective corresponding sequences derived from mAb55. To this end, we constructed: (a) the recV,13-55 gene segment, by juxtaposing the mAb13-derived VK sequence, encoding the FR1-FR3, with the mAb55-derived V~-J~ sequence, encoding the CDR3-FR4; and (b) the recV~55-13 gene segment, by juxtaposing the mAb55-derived V~ sequence, encoding the FR1-FR3, with the mAb13-derived V~-J, sequence, encoding the CDR3-FR4. The two chimeric gene segments were inserted into the C~ pSXRDIG vectors, and separately expressed by transfection of F3B6 cells as paired with the recV.13-55 gene segment, to yield recV.13-55/recVA3-55 and recV.13-55/recV~55-13 molecules. Grafting of the mAb55-derived V~FR1-FR3 sequence, but not the K chain CDR3-FR4 sequence, onto the L chain of the recV.13-55/recVA3-13 molecule significantly enhanced the multiple Ag-binding activity of this Ab (Fig.  4, K and J) . In fact, the recV.13-55/recV~55-13 molecule bound multiple Ags with an efficiency (Av=l for insulin, 8.4 x 10 -7 g/#l) comparable to that of the integral reclgG55 Ab (Fig. 4 B) . The germline configuration of the mAb55-derived V,325 FR1-FR3 segment is crucial in Ag-binding by the autologous H chain CDR3, but may not be sufficient to independently provide a structural correlate for polyreactivity, as grafting of the mAb55-derived V~ gene segment onto a molecule encoded in all other parts by mAb13-derived gene segments failed to generate a polyreactive Ab. Instead, this Ab, recV.13-13/recV~55-13, bound specifically to insulin but to none of the other Ags (Fig. 4 L) . Its exquisite specificity for insulin (Av=l, 6.0 x 10 -9 g/#l) was comparable to that measured for reclgG13 and that of the original mAb13 (Fig.  4, D and C) .
Discussion
In the present studies, we investigated the contributions of valency and of primary structure of V segments to the multiple Ag-binding of a human polyreactive IgM Ab, mAb55. The recombinant Ig V, and VL gene expression system we adopted was designed to produce a complete human IgG1 K molecule. Accordingly, the IgM mAb55-derived V.-D-J. and V~-J~ gene segments were expressed and secreted as a recombinant bivalent monomer (designated reclgG55), effectively "switching" the polyreactive IgM to IgG. On a weight-to-weight basis, the multiple Ag-binding of the reclgG55 molecule closely mimicked that of the wild-type IgM mAb55, showing that IgM to IgG class switch does not necessarily affect the characteristic feature of a polyreactive Ab, and that recognition of multiple Ags is a function that is absolutely restricted to the Ig V domains. This finding suggests that the role of natural polyreactive IgM extends far beyond that of providing the structural elements of the idiotypic regulatory network in early ontogeny, and that of enhancing opsonization and/or complement activation after binding invading microorganisms in the early phases of infection. Natural polyreactive IgM-producing cells may include the precursors of cells producing high-affinity polyreactive IgG or IgA autoantibodies or Abs to exogenous microbial Ags, after undergoing an Ag-dependent process of clonal activation and expansion entailing class switch and, possibly, somatic mutation and Ag selection (8) (9) (10) .
The experiments involving the hybrid IgG molecules generated by coexpressing the mAb55-derived H or K chain V segment with the mAb13-derived K or H chain V segment, respectively, clearly demonstrated that the H chain plays a major role in mAb55 polyreactivity. This is consistent with previous observations that the specificity of monoreactive-specific Abs and autoantibodies is mainly determined by the H chain V segment (26, 27) , although in some cases the L chain seems to play a critical role in defining epitope specificity (28, 29) . Individual Ig H chains can bind Ag independently of the contribution of any L chain, as originally shown by Utsumi and Karush (30) in an isolated rabbit H chain to p-azophenyl-/3-1actoside, and by Jaton et al. (31) in an isolated rabbit H chain to the 2,4-dinitrophenyl group. These early findings have recently been extended by experiments showing efficient Ag-binding of cloned murein V, domains, "single domain antibodies" to lysozyme or KLH (32) , and by the observation that a broad Ag-binding repertoire is provided by naturally occurring Ig H chain dimers in the camel (33) . Finally, x-ray crystallography has demonstrated in at least three AgAb systems that the number of Ag-contacting residues in the H chain far exceeds that in the L chain (34, 35) .
The experiments, in which the presence or absence of the mAb55-derived H chain CDR3 sequence resulted in acquisi-
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Structural Correlates for Antibody Polyreactivity tion or abolition, respectively, of polyreactivity, whether in a mAb55 or mAbl3-1ike structural context, indicated that the CDK3 provides a critical structural correlate for the multiple Ag-binding activity of mAb55. The generated chimeric molecules satisfied the criteria set by Chothia and Lesk (26), i.e., they were identical in those canonical Flk sequences that are adjacent to the CDKs, and are critical for the full preservation of the CDR. loop structure. Thus, our choice of Abs and experimental design for shuffling the FK and CDR. sequences should have prevented the structural deleterious effects which might be observed when CDtt. sequences are grafted onto FR contexts different from those of the original Ab molecule (37, 38) . The H chain CDlk3 of mAb55 is exceptionally long (31 amino acids), identifying a structure potentially capable of providing multiple contact interfaces, which may partially overlap, for different epitopes (1, 39) . Crystallographic analysis has shown that at least in the case of relatively large protein Ags, multiple residues within the H chain CDK3 interface with Ag even in specific (monoreactive) Abs (35, 40, 41) . However, as suggested by Chothia and Lesk (26) , the important role of the H chain CDR3 in Ab specificity may arise from the central position of this structural element in the binding site rather than from its sheer size (or number of contact residues). In at least some polyreactive Abs, a wide H chain CDR3 loop may be critical for accommodating different Ags, but relatively short H chain CDR3s have been reported in other human polyreactive Abs (5, 7-12). In fact, the H chain CDR3 structures of human polyreactive Abs so far described are highly divergent in length and composition, and do not allow for the identification of any obvious common motif possibly responsible for polyreactivity (5) (6) (7) (8) (9) (10) (11) (12) . This structural heterogeneity might underlie the functional "uniqueness" i.e., the discrete Ag-binding features, of each polyreactive mAb (5, 8, 9 ), but at the same time it raises the possibility that, in certain Abs, polyreactivity is mediated primarily by structures other than the H chain CDR3. An important role of the H chain CDR3 in providing the structural correlate for multiple Ag-binding has been suggested by Harindranath et al. (6) Abs utilizing a H chain other than SMI was polyreactive, suggesting that the polyreactivity of SMI was dependent on the structure of the H chain CDR3. Our findings strengthen these observations by directly demonstrating that the grafting of the H chain CDtk3 of a polyreactive Ig onto an originally monoreactive Ig results in multiple Ag-binding, and show further that an appropriate L chain V segment is necessary to fully express the polyreactive potential of the Ig H chain CDR3. Other L chains have been shown to not only contribute to Ag specifidty of polyreactivity but also to efficiently bind Ags independently of H chains. Dimers of the MOPC 315 L chain bind e-N-(2,4 dinitrophenyl)-t.-lysine and 4-(ot-N-alanine)-7-nitrobenz-2-oxa-1, 3-diazide (42, 43) ; and dimers of the L chain Bence-Jones Mcg protein bind dinitrophenyl compounds, e-dansyUysine, colchichine, 1,10-phenanthroline, methadone, morphine, meperidine, 5-acetyluracil, caffeine, theophylline, menadione (vitamin K3), triacetin, and other compounds (44, 45) . In the case of mAb55, the direct multiple Ag-binding activity of the V~325 segment remains to be defined as this V~ segment failed to generate a polyreactive Ab when paired with the V, segment of mAbl3. The FR1-FR3 sequence of the mAb55-derived r chain V segment is identical to the FR1-FR3 sequence of the germline kv325 gene, and to that of the V~ (SMI) segment used by Martin et al. (14) to express the polyreactivity of the SMI H chain. In fact, the mAb55 and SMI K chains are identical not only in their FR1-FR.3 sequence, but also in their FR.4 sequence, and in the first seven of nine amino acids of the CDR3. The kv325 and other closely related segments of the V~IIIb subgroup are frequently utilized to encode natural polyreactive Abs, as well as disease-associated autoantibodies, particularly RFs in autoimmune patients and chronic lymphocytic leukemia patients (20, 24, 46) . The FR residues of V,IIIb segments, which are putatively involved in the binding of the IgG Fc fragment (47) , may also serve in stabilizing or defining the multiple Ag-binding site in polyreactive Abs.
Although limited to a single Ab pair, the present findings suggest that both monoreactive and polyreactive Ag-binding sites can be generated utilizing identical H and L chain V gene segments in conjunction with discrete primary structures of the H chain CDR3 (see Fig. 4 , K and L). Previous observations have shown that the pool of V. genes used by polyreactive natural Abs overlaps, at least partially, with that of V. genes recruited in high-affinity immune responses to foreign Ags in healthy subjects or to self Ags in autoimmune patients patients (1, 5-10, 16, 24, 48) . In contrast, the H chain CDR3 constitutes an important source of diversity in the expressed Ab repertoire, since its structure results from complex somatic rearrangement events, often involving more than one D gene in different orientations, and "unencoded" nucleotide additions (19, 49, 50) . Computer analysis by Sanz (50) of more than 500 sequences from a CDR3-spedfic cDNA library revealed that these human Ig H chain sequences have the potential to generate more than 1014 different peptides. In view of the findings of Martin et al. (14) , however, only a minority of somatically generated H chain CDR3s would give rise to Abs binding multiple Ags. The frequency of fully polyreactive Abs would be further reduced by the requirement for an appropriate L chain V segment, as shown here, and/or other H or L chain structures. This expected paucity of newly generated polyreactive Abs contrasts with the consistent findings that polyreactive Ab-producing cells account for up to 30% of the adult, and possibly more of the neo-natal, human B cell repertoire (for a review see reference 51). Polyreactive Ab-producing cell precursors may be positively selected by contact with self Ags in early ontogeny, in a fashion similar to T cells in the thymus, where cells bearing receptors with low affinity for self Ags are recruited along the T cell maturation pathway (52) . A somatic selection and amplification of human polyreactive Ab-producing cell clones would be further supported by the findings suggesting that most of the peripheral blood B cells in mice are ligand selected (53) . The extension of combined structural and functional studies to other polyreactive Abs may help define the generality of the present findings and elucidate the role of these Abs in development and disease.
